Your browser doesn't support javascript.
loading
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells.
Sasu, Barbra J; Opiteck, Gregory J; Gopalakrishnan, Suhasni; Kaimal, Vivek; Furmanak, Tom; Huang, David; Goswami, Angshumala; He, Ying; Chen, Jiamin; Nguyen, Anh; Balakumaran, Arun; Shah, Nirav N; Hamadani, Mehdi; Bone, Kathleen M; Prashad, Sacha; Bowen, Michael A; Pertel, Thomas; Embree, Heather D; Gidwani, Shalini G; Chang, David; Moore, Alison; Leonard, Mark; Amado, Rafael G.
Afiliação
  • Sasu BJ; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Opiteck GJ; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Gopalakrishnan S; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Kaimal V; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Furmanak T; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Huang D; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Goswami A; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • He Y; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Chen J; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Nguyen A; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Balakumaran A; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Bone KM; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Prashad S; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Bowen MA; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Pertel T; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Embree HD; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Gidwani SG; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Chang D; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Moore A; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Leonard M; Allogene Therapeutics, South San Francisco, CA 94080, USA.
  • Amado RG; Allogene Therapeutics, South San Francisco, CA 94080, USA. Electronic address: rafael.amado@allogene.com.
Mol Ther ; 31(3): 676-685, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36518079
ABSTRACT
A chromosome 14 inversion was found in a patient who developed bone marrow aplasia following treatment with allogeneic chimeric antigen receptor (CAR) Tcells containing gene edits made with transcription activator-like effector nucleases (TALEN). TALEN editing sites were not involved at either breakpoint. Recombination signal sequences (RSSs) were found suggesting recombination-activating gene (RAG)-mediated activity. The inversion represented a dominant clone detected in the context of decreasing absolute CAR Tcell and overall lymphocyte counts. The inversion was not associated with clinical consequences and wasnot detected in the drug product administered to this patient or in any drug product used in this or other trials using the same manufacturing processes. Neither was the inversion detected in this patient at earlier time points or in any other patient enrolled in this or other trials treated with this or other product lots. This case illustrates that spontaneous, possibly RAG-mediated, recombination events unrelated to gene editing can occur in adoptive cell therapy studies, emphasizes the need for ruling out off-target gene editing sites, and illustrates that other processes, such as spontaneous V(D)J recombination, can lead to chromosomal alterations in infused cells independent of gene editing.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos